EIF5 and hepatocellular carcinoma: Experiments using HCC cells in culture and subcutaneous xenograft models showed that miR-103a promoted glucose metabolism and directly inhibited cell death by targeting ATP11A and EIF5 transcripts, therefore, suggesting a regulatory mechanism(s) for HCC progression [64].